Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of Mediterranean diet on coronary plaque vulnerability, microvascular function, inflammation and microbiome after an acute coronary syndrome: study protocol for the MEDIMACS randomized, controlled, mechanistic clinical trial.
Fernández AI, Bermejo J, Yotti R, Martínez-Gonzalez MÁ, Mira A, Gophna U, Karlsson R, Al-Daccak R, Martín-Demiguel I, Gutiérrez-Ibanes E, Charron D, Fernández-Avilés F; MEDIMACS research team. Fernández AI, et al. Among authors: charron d. Trials. 2021 Nov 12;22(1):795. doi: 10.1186/s13063-021-05746-z. Trials. 2021. PMID: 34772433 Free PMC article.
Editorial: Alloimmune Response From Regenerative Medicine.
Al-Daccak R, Charron D. Al-Daccak R, et al. Among authors: charron d. Front Immunol. 2019 Jan 18;9:3121. doi: 10.3389/fimmu.2018.03121. eCollection 2018. Front Immunol. 2019. PMID: 30713534 Free PMC article. No abstract available.
Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
Sanz-Ruiz R, Casado Plasencia A, Borlado LR, Fernández-Santos ME, Al-Daccak R, Claus P, Palacios I, Sádaba R, Charron D, Bogaert J, Mulet M, Yotti R, Gilaberte I, Bernad A, Bermejo J, Janssens S, Fernández-Avilés F. Sanz-Ruiz R, et al. Among authors: charron d. Circ Res. 2017 Jun 23;121(1):71-80. doi: 10.1161/CIRCRESAHA.117.310651. Epub 2017 May 22. Circ Res. 2017. PMID: 28533209 Clinical Trial.
Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F, Sanz-Ruiz R, Bogaert J, Casado Plasencia A, Gilaberte I, Belmans A, Fernández-Santos ME, Charron D, Mulet M, Yotti R, Palacios I, Luque M, Sádaba R, San Román JA, Larman M, Sánchez PL, Sanchís J, Jiménez MF, Claus P, Al-Daccak R, Lombardo E, Abad JL, DelaRosa O, Corcóstegui L, Bermejo J, Janssens S. Fernández-Avilés F, et al. Among authors: charron d. Circ Res. 2018 Aug 17;123(5):579-589. doi: 10.1161/CIRCRESAHA.118.312823. Circ Res. 2018. PMID: 29921651 Clinical Trial.
MHC class II signaling in antigen-presenting cells.
Al-Daccak R, Mooney N, Charron D. Al-Daccak R, et al. Among authors: charron d. Curr Opin Immunol. 2004 Feb;16(1):108-13. doi: 10.1016/j.coi.2003.11.006. Curr Opin Immunol. 2004. PMID: 14734118 Review.
590 results